Literature DB >> 12069581

Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides.

Shiroh Futaki1, Ikuhiko Nakase, Tomoki Suzuki, Zhang Youjun, Yukio Sugiura.   

Abstract

A basic peptide derived from HIV-1 Tat has been reported to have the ability to translocate through cell membranes and to bring exogenous proteins into cells. We have demonstrated that these features could be observed among many arginine-rich peptides, and the presence of a ubiquitous internalization mechanism for arginine-rich oligopeptides has been suggested. In this report, we report that these features are also applicable to the peptides having branched-chain structures. Peptides that have arginine residues on four branched chains (R(n))(4) [n (number of arginine residues)= 0-6] were prepared. Fluorescence microscopic observation revealed that the (R(2))(4) peptide exhibited the most efficient translocation. The dependence on the number of arginine residues of the translocation efficiency and cellular localization was also observed for the branched-chain peptides as was seen in the linear peptides. Quite interestingly, efficient translocation was also recognized in the (RG(3)R)(4) peptide, where three glycine residues intervened between two arginine residues on each chain of (R(2))(4). The results strongly suggested that a linear structure was not indispensable for the translocation of arginine-rich peptides and that there could be considerable flexibility in the location of the arginine residue in the molecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069581     DOI: 10.1021/bi0256173

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Cooperative domains define a unique host cell-targeting signal in Plasmodium falciparum-infected erythrocytes.

Authors:  Carlos Lopez-Estraño; Souvik Bhattacharjee; Travis Harrison; Kasturi Haldar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

2.  New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Authors:  J P M Langedijk; T Olijhoek; D Schut; R Autar; R H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

3.  Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.

Authors:  Pinaki R Desai; Punit P Shah; Ram R Patlolla; Mandip Singh
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

4.  Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA.

Authors:  David I Bryson; Wenyu Zhang; Patrick M McLendon; Theresa M Reineke; Webster L Santos
Journal:  ACS Chem Biol       Date:  2011-10-28       Impact factor: 5.100

Review 5.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

Review 6.  The design of guanidinium-rich transporters and their internalization mechanisms.

Authors:  Paul A Wender; Wesley C Galliher; Elena A Goun; Lisa R Jones; Thomas H Pillow
Journal:  Adv Drug Deliv Rev       Date:  2007-11-09       Impact factor: 15.470

7.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

8.  Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans.

Authors:  Alfredo M Angeles-Boza; Alfredo Erazo-Oliveras; Ya-Jung Lee; Jean-Philippe Pellois
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

9.  Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells.

Authors:  H-L Lee; E A Dubikovskaya; H Hwang; A N Semyonov; H Wang; L R Jones; R J Twieg; W E Moerner; P A Wender
Journal:  J Am Chem Soc       Date:  2008-06-26       Impact factor: 15.419

10.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.